Research opportunities in prevention and population research
We support a broad portfolio of prevention and population research aimed at understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions.
Our research strategy is driven by patient and public benefit, and we aim to fund research that has the potential for practical impact on clinical practice or public policy.
We fund investigator-led projects, partnership initiatives and invest in research facilities and resources. We're also committed to supporting the next generation of cancer researchers, and have a range of opportunities to help you develop your research career or apply your population research expertise to cancer for the first time.
We have a range of grants available for you or your research group, whether you're looking for programme funding for your lab, grants for specific projects, or fellowship funding to develop your career.
|Prevention and Population Research Programme Award
Provides long-term support for broad, multidisciplinary research with transformative potential in prevention and population research.
|Prevention and Population Research Project Award
Provide support for focused research proposals centred on key questions in prevention and population research.
Enables translational research by funding cross-institutional teams to produce tools, platforms and resources which will transform the research landscape.
|Population Research Postdoctoral Fellowship
Provides 3 years support for outstanding postdocs to develop their careers in the field.
|Prevention Research Consortium Award
UKPRP Consortium Awards provide substantial, long-term investment for interdisciplinary research addressing a specific challenge in primary prevention of NCDs.
|Prevention Research Network Award
UKPRP Network Awards will build a community of researchers and users around a broad NCD primary prevention research challenge and support interdisciplinary networking.
|Tobacco Advisory Group Project Grant
Provides funding to researchers or advocacy organisations for policy research and advocacy activities in tobacco control.
|Early-Phase Trials and Feasibility Study Award
Supports studies that test the viability of larger trials, including the ability to recruit and/or to explore tolerability or efficacy of treatments.
Opportunities for early-career researchers
We're committed to supporting the next generation of cancer researchers, and we have a range of opportunities for students, post-docs and early- and mid-career group leaders, from studentships and fellowships to training and travel grants.
Featured funding opportunities
Population Research Postdoctoral Fellowships
Provide 3 years support for outstanding postdocs to develop their careers in the field.
AACR-CRUK Transatlantic Fellowships
Support high-potential UK postdocs to develop their independent career in the US, and vice versa.
We fund the best research from the best researchers, across the spectrum of population research related to cancer. We focus our portfolio on research which has the potential to make a practical impact on clinical practice or public policy for patient and public benefit.
You can find out who we have recently funded, or browse the case studies below for a taste of the kinds of projects and programmes that we support.
Richard Martin, Professor of Clinical Epidemiology and leader of the CRUK-funded CAP trial of prostate cancer screening, talked to us about the impact of the study and the advice he’d give researchers seeking funding for population research.
We've launched an international collaboration to answer the final questions before aspirin could be recommended to reduce cancer risk, funded by our Catalyst Award.
We caught up with Willie Hamilton and Fiona Walter to find out why, with appropriate safeguards, making patient data accessible for research is so important for beating cancer sooner.
We believe earlier detection and diagnosis of cancer offers the greatest potential for transformational improvements in patient outcomes, and we have a range of opportunities in this field.
We support a broad portfolio of clinical and translational research through response mode funding, initiatives and investments in clinical infrastructure.
Our ambition is to accelerate progress to see 3 in 4 people with cancer surviving the disease by 2034. Our Research Strategy outlines how we will achieve our objectives through a substantial increase in research in priority areas.